glp 1 gpi The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Naturally optimize your appetite Glucagon-Like Peptide-1 Based Therapies: A

Importantly, clinical studies reveal a reduction in alcohol drinking in AUD patients by these agents ( 1.2

The implications are significant: Repurposing an inexpensive, widely available drug Targeting the intersection of inflammasome activation, TP53 dysfunction, and neoplastic risk Potential relevance for disorders ranging from CAPS and histiocytosis to MDS and beyond We urgently need more translational work on this underappreciated molecule

Chang CH, Tsai WC, Hsu YH, Pang JHS

This preventive approach addresses a modifiable risk factor and may reduce back and muscle pain before it develops

Exercise is important for health but its not the answer to losing weight

Many of the acute changes that occur with CS are routinely overlooked